AMOREPACIFIC CORPORATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- -
- Established
- 2006-01-01
- Employees
- -
- Market Cap
- -
Anti-pollution Effects of AP Green Tea Extracts
Not Applicable
Completed
- Conditions
- Respiratory Conditions Due to Unspecified External Agent
- Interventions
- Dietary Supplement: AP green tea extracts
- First Posted Date
- 2020-04-09
- Last Posted Date
- 2021-06-16
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 40
- Registration Number
- NCT04340375
- Locations
- 🇰🇷
Hanyang University Seoul Hospital, Seoul, Korea, Republic of
CAPTAIN-AD: Clinical Study of AmorePacific's TRPV1 Antagonist in Atopic Dermatitis
Phase 3
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2016-11-16
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 240
- Registration Number
- NCT02965118
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis
Phase 2
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2016-05-02
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 192
- Registration Number
- NCT02757729
- Locations
- 🇰🇷
Chung-ang University Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Seborrheic Dermatitis
Phase 2
Completed
- Conditions
- Seborrheic Dermatitis
- Interventions
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2016-04-25
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 75
- Registration Number
- NCT02749383
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis
Phase 1
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2016-04-22
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 56
- Registration Number
- NCT02748993
- Locations
- 🇰🇷
Chung-ang University Hospital, Seoul, Korea, Republic of
🇰🇷Konkuk University Hospital, Seoul, Korea, Republic of
🇰🇷Seoul National University Hospital, Seoul, Korea, Republic of
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea
Phase 2
Completed
- Conditions
- Rosacea
- Interventions
- First Posted Date
- 2015-10-21
- Last Posted Date
- 2016-09-20
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 216
- Registration Number
- NCT02583009
- Locations
- 🇰🇷
Korea University Ansan Hospital, Ansan si, Gyeonggi-do, Korea, Republic of
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Atopic Dermatitis
Phase 2
Completed
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2015-10-21
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 74
- Registration Number
- NCT02583022
A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Skin Pruritus
Phase 2
Completed
- Conditions
- Skin Pruritus
- Interventions
- First Posted Date
- 2015-10-01
- Last Posted Date
- 2016-07-15
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 296
- Registration Number
- NCT02565134
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
A Study to Assess the Safety, Tolerability and Pharmacokinetics of PAC-14028 Cream in Healthy Male Subjects
- First Posted Date
- 2014-12-05
- Last Posted Date
- 2016-04-22
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 24
- Registration Number
- NCT02309008
- Locations
- 🇰🇷
Seoul National University Hospital Clinical Trials Center, Seoul, Korea, Republic of
Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients
Phase 2
Completed
- Conditions
- Erythematotelangiectatic RosaceaPapulopustular Rosacea
- Interventions
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2014-02-03
- Lead Sponsor
- Amorepacific Corporation
- Target Recruit Count
- 80
- Registration Number
- NCT02052999
- Locations
- 🇰🇷
Chung-Ang University Hospital, Seoul, Korea, Republic of